Przejdź do komentarzy
Przejdź do komentarzy

Regulatory management option analysis

The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

 

Disclaimer to the RMOA list

The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.

RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.

Last updated 26 listopada 2020. Database contains 260 unique substances/entries.
Filter the list
Date of intention:
Date of RMOA conclusion:
Latest update:

 
202-051-6
91-22-5
Ireland
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/07/2015
Details
202-112-7
91-97-4
Germany
Mutagenic
Persistence
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
202-422-2
95-47-6
Germany
Carcinogenic
Mutagenic
Respiratory sensitiser
STOT RE
Toxic for reproduction
Under development
Under development
No suggestion yet
24/06/2020
Details
202-679-0
98-54-4
Germany
Endocrine disruption
Other human toxicity
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/10/2019
Details
202-681-1
98-56-6
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
202-696-3
98-73-7
Belgium
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
202-716-0
98-95-3
Austria
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
03/07/2015
Details
202-830-0
100-21-0
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
None
07/03/2017
Details
202-851-5
100-42-5
Denmark
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
12/11/2014
Details
202-853-6
100-44-7
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
202-859-9
100-51-6
Germany
Carcinogenic
Mutagenic
Respiratory sensitiser
STOT RE
Toxic for reproduction
Under development
Under development
No suggestion yet
24/06/2020
Details
202-924-1
101-20-2
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
10/08/2018
Details
202-966-0
101-68-8
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
202-966-0
101-68-8
Denmark
Carcinogenic
Mutagenic
Other human toxicity
Persistence
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
203-080-7
103-11-7
Sweden
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
15/08/2017
Details
203-293-5
105-38-4
Sweden
Carcinogenic
Mutagenic
Under development
Under development
No suggestion yet
17/01/2020
Details
203-396-5
106-42-3
Germany
Carcinogenic
Mutagenic
Respiratory sensitiser
STOT RE
Toxic for reproduction
Under development
Under development
No suggestion yet
24/06/2020
Details
203-404-7
106-50-3
Netherlands
Other environmental toxicity
Other human toxicity
Concluded
Appropriate to initiate regulatory risk management action
CLH
Restriction
24/05/2019
Details
203-439-8
106-89-8
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
203-444-5
106-93-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other
Other legislation
07/08/2015
Details
203-466-5
107-13-1
Germany
Mutagenic
Other human toxicity
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
23/09/2014
Details
EDA
203-468-6
107-15-3
ECHA
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
13/10/2016
Details
203-471-2
107-19-7
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
09/11/2017
Details
203-473-3
107-21-1
Netherlands
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
06/07/2020
Details
203-545-4
108-05-4
Sweden
Carcinogenic
Mutagenic
Under development
Under development
No suggestion yet
17/01/2020
Details
203-576-3
108-38-3
Germany
Carcinogenic
Mutagenic
Respiratory sensitiser
STOT RE
Toxic for reproduction
Under development
Under development
No suggestion yet
24/06/2020
Details
203-585-2
108-46-3
Finland
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
CLH
05/09/2019
Details
203-625-9
108-88-3
Denmark
Mutagenic
Toxic for reproduction
Widespread use
Concluded
No need to initiate further regulatory risk management action at this time
None
12/01/2017
Details
203-625-9
108-88-3
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
Other
14/07/2020
Details
203-632-7
108-95-2
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
203-726-8
109-99-9
Germany
Carcinogenic
Mutagenic
Respiratory sensitiser
STOT RE
Toxic for reproduction
Under development
Under development
No suggestion yet
24/06/2020
Details
203-750-9
110-26-9
Sweden
Carcinogenic
Mutagenic
Under development
Under development
No suggestion yet
08/04/2020
Details
203-772-9
110-49-6
Sweden
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
29/11/2018
Details
203-777-6
110-54-3
Germany
Carcinogenic
Mutagenic
Respiratory sensitiser
STOT RE
Toxic for reproduction
Under development
Under development
No suggestion yet
24/06/2020
Details
203-856-5
111-30-8
Sweden
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
SVHC
25/11/2020
Details
204-112-2
115-86-6
France
Endocrine disruption
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
11/09/2019
Details
204-118-5
115-96-8
Denmark
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
04/08/2016
Details
204-126-9
116-14-3
Ireland
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
05/12/2018
Details
204-260-8
118-56-9
France
Endocrine disruption
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
03/05/2019
Details
204-327-1
119-47-1
Denmark
Toxic for reproduction
Under development
Under development
No suggestion yet
02/06/2020
Details
204-661-8
123-91-1
Germany
Bioaccumulation
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
Restriction
23/06/2020
Details
204-826-4
127-19-5
Commission
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
26/10/2018
Details
204-881-4
128-37-0
France
Carcinogenic
Endocrine disruption
Exposure
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
17/01/2019
Details
204-927-3
129-00-0
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
205-028-9
131-55-5
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
205-029-4
131-56-6
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
205-031-5
131-57-7
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
01/04/2015
Details
205-288-3
137-30-4
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
205-355-7
139-13-9
Ireland
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
12/01/2017
Details
205-391-3
140-01-2
France
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
01/04/2016
Details

Export search results to:

Categories Display


Route: .live2